schizophrenia

March 19, 2015

Multi-sensory processing model explores autism, schizophrenia

There is growing evidence that disorders such as autism and schizophrenia involve deficits in what is called “multi-sensory processing,” the ability of the brain to properly integrate information coming in through the eyes, ears and other senses.

By Bill Snyder
Scanning of a human brain by X-rays
February 12, 2015

Grant spurs schizophrenia research

Vanderbilt University is partnering with the William K. Warren Foundation of Tulsa, Oklahoma, on research aimed at improving the treatment of schizophrenia and other forms of serious mental illness.

By Bill Snyder
sad man
February 12, 2015

Hazy definition may hamper catatonia care

Catatonia, a syndrome characterized by muscular rigidity and a trance-like mental stupor, can at times manifest with great excitement and confusion. And while it is often associated with schizophrenia, it can present in patients with either medical or psychiatric conditions. For this reason, the condition has often confused clinicians.

By Nancy Humphrey
January 23, 2015

New view of dopamine heteromers

Although heteromeric dopamine receptors composed of both D1 and D2 subunits have been proposed to play a role in depression and schizophrenia, recent studies suggest these heteromers do not exist.

By VUMC News and Communications
December 18, 2014

Family’s gift bolsters schizophrenia research, treatment

A “transformational” $6.4 million gift from Dallas couple Donald Test Jr., and his wife, Charlotte, who have a very personal connection to the devastating disease of schizophrenia, is supporting Vanderbilt Department of Psychiatry research and treatment into schizophrenia and related disorders.

By Nancy Humphrey
September 18, 2014

VU study reveals shared pathways in psychiatric disorders

Schizophrenia and bipolar disorder share common genetic underpinnings. Vanderbilt researchers combined high-resolution gene expression studies with gene association data to reveal signaling pathways linked to schizophrenia and bipolar disorder.

By Leigh MacMillan
September 12, 2014

Schizophrenia ‘switches’ discovered

Drugs developed at Vanderbilt could provide a new way to treat schizophrenia in a personalized way.
By Bill Snyder
March 13, 2014

‘Missing link’ may spur new brain disorder drugs

Researchers at the Scripps Research Institute in San Diego and Vanderbilt University have discovered a “missing link” in the structure of a transmembrane receptor that could lead to new treatments for autism, schizophrenia, Parkinson’s disease and Alzheimer’s disease.
By Bill Snyder
January 14, 2014

Vanderbilt study reveals senses of sight and sound separated in children with autism

Children with autism spectrum disorders have trouble integrating simultaneous information from their eyes and their ears--as if they experience the world like a badly-dubbed movie.
By Craig Boerner
September 19, 2013

Transporter linked to autism risk

Vanderbilt University investigators for the first time have linked a non-inherited, de novo mutation in the dopamine transporter to autism spectrum disorder (ASD).
By Bill Snyder
October 18, 2012

Nobel in Chemistry reveals VU ties that bind

Several Vanderbilt researchers have collaborated with this year's Nobel Chemistry winners.
By Bill Snyder
July 17, 2012

Insights for neuroscience drug discovery

When discovering drugs for brain disorders, it’s important to test the candidates in multiple ways to avoid advancing those with restricted physiological effects.
By Leigh MacMillan
May 11, 2012

Perfect timing for sensory processing

Identification of brain regions involved in processing sights and sounds may offer insights into disorders like autism and dyslexia.
By VUMC News and Communications
1 2 3 4